IMMUCELL CORP /DE/ Stockholders Equity

Quick Answer

IMMUCELL CORP /DE/ reported Stockholders Equity of $27.06 million for the year ending 2025.

  • IMMUCELL CORP /DE/ showed a decrease of -1.7% in Stockholders Equity from 2024 to 2025.
  • This data is from IMMUCELL CORP /DE/'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2013: $9.41 million | Q2 2013: $9.45 million | Q3 2013: $9.51 million | Q1 2014: $9.39 million | Q2 2014: $9.10 million | Q3 2014: $9.12 million | Q1 2015: $9.74 million | Q2 2015: $9.90 million | Q3 2015: $10.30 million | Q1 2016: $16.32 million | Q2 2016: $16.31 million | Q3 2016: $16.41 million | Q1 2017: $20.37 million | Q2 2017: $20.20 million | Q3 2017: $20.95 million | Q1 2018: $23.49 million | Q2 2018: $22.81 million | Q3 2018: $22.67 million | Q1 2019: $30.25 million | Q2 2019: $29.65 million | Q3 2019: $29.19 million | Q1 2020: $28.99 million | Q2 2020: $28.28 million | Q3 2020: $28.02 million | Q1 2021: $27.87 million | Q2 2021: $32.27 million | Q3 2021: $32.46 million | Q1 2022: $33.15 million | Q2 2022: $32.55 million | Q3 2022: $31.98 million | Q1 2023: $28.16 million | Q2 2023: $26.86 million | Q3 2023: $26.01 million | Q1 2024: $24.64 million | Q2 2024: $23.46 million | Q3 2024: $26.41 million | Q1 2025: $28.99 million | Q2 2025: $29.87 million | Q3 2025: $29.80 million.
  • Over the full 18 years of available data (2008 to 2025), IMMUCELL CORP /DE/'s Stockholders Equity has grown by 180.6%.
  • Historical annual values: Fiscal year 2025: $27.06 million | Fiscal year 2024: $27.52 million | Fiscal year 2023: $24.99 million | Fiscal year 2022: $30.38 million | Fiscal year 2021: $32.58 million | Fiscal year 2020: $28.27 million | Fiscal year 2019: $28.99 million | Fiscal year 2018: $21.74 million | Fiscal year 2017: $23.59 million | Fiscal year 2016: $19.72 million | Fiscal year 2015: $10.61 million | Fiscal year 2014: $9.26 million | Fiscal year 2013: $9.40 million | Fiscal year 2012: $9.19 million | Fiscal year 2011: $9.02 million | Fiscal year 2010: $9.28 million | Fiscal year 2009: $9.62 million | Fiscal year 2008: $9.64 million.
  • Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: